title: Evaluation of apoptosis and cell proliferation in experimentally induced renal cysts.
abstract: Cell proliferation and apoptosis in renal cysts induced by streptozotocin, alloxan and ferric-nitrilotriacetate were investigated in rats. In the kidneys of all treated animals dilated tubules at the cortico-medullary region, large cysts, glomerular cysts and tubular dilation in the medullary area were found. Both cell proliferation and apoptosis were increased in the epithelium of the non-dilated tubules, in the mesangial and interstitial cells. Cells lining the dilated tubules or cysts demonstrated apoptosis but their proliferating activity was low. By calculating the proliferation-apoptosis ratio we found that alloxan did not change the balance between the two mechanisms. Meanwhile streptozotocin resulted in an increased apoptosis and ferric-nitrilotriacetate in an increased cell proliferation. p53 expression might be responsible for the uncontrolled proliferation in rats treated with ferric-nitrilotriacetate as this oncoprotein was diffusely present in tubular cell nuclei. The observed apoptosis seemed to be independent of bcl-2 oncoprotein expression. We assume that the initial factor in such cystogenesis should be a cellular injury due to direct toxic or to the diabetogenic effect of the drugs. The latter is more likely as all the animals were hyperglycemic and insulin treatment following administration of streptozotocin prevented the morphologic changes.
authors.affiliation: Department of Pathology, University Medical School of Debrecen, Hungary.
authors.forename: J
authors.initials: J
authors.lastname: Kovács
authors.forename: M
authors.initials: M
authors.lastname: Zilahy
authors.forename: T
authors.initials: T
authors.lastname: Bányász
authors.forename: S
authors.initials: S
authors.lastname: Gomba
mesh_terms: D000496:Alloxan; D000818:Animals; D000903:Antibiotics, Antineoplastic; D017209:Apoptosis / Q000235:genetics*; D001786:Blood Glucose; D002273:Carcinogens; D002455:Cell Division / Q000502:physiology; D005260:Female; D005290:Ferric Compounds; D007684:Kidney Tubules / Q000378:metabolism / Q000473:pathology*; D008297:Male; D009571:Nitrilotriacetic Acid / Q000031:analogs & derivatives; D007690:Polycystic Kidney Diseases / Q000139:chemically induced / Q000378:metabolism / Q000473:pathology*; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000096:biosynthesis; D051381:Rats; D011916:Rats, Inbred F344; D013311:Streptozocin; D016159:Tumor Suppressor Protein p53 / Q000096:biosynthesis
chemical_list: D000903:Antibiotics, Antineoplastic; D001786:Blood Glucose; D002273:Carcinogens; D005290:Ferric Compounds; D019253:Proto-Oncogene Proteins c-bcl-2; D016159:Tumor Suppressor Protein p53; D013311:Streptozocin; D000496:Alloxan; D009571:Nitrilotriacetic Acid; C020326:ferric nitrilotriacetate